Development
NP Life Sciences Health Industry Group Inc.
NPLS
$0.0539
-$0.0962-64.09%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 200.60K | 224.10K | 132.00K | 102.00K | 91.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 200.60K | 224.10K | 132.00K | 102.00K | 91.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 200.60K | 224.10K | 132.00K | 102.00K | 91.00K |
| SG&A Expenses | 148.90K | 140.30K | 118.50K | 120.80K | 94.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 148.90K | 140.30K | 118.50K | 120.80K | 94.10K |
| Operating Income | 51.80K | 83.80K | 13.50K | -18.80K | -3.10K |
| Income Before Tax | 51.30K | 83.60K | 13.50K | -18.80K | -3.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.05 | 0.08 | 0.01 | -0.02 | 0.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.30K | 83.60K | 13.50K | -18.80K | -3.10K |
| EBIT | 51.80K | 83.80K | 13.50K | -18.80K | -3.10K |
| EBITDA | -- | -- | -- | -- | 32.70K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 171.84M | 171.84M | 171.84M | 171.84M | 171.84M |
| Average Diluted Shares Outstanding | 171.84M | 171.84M | 171.84M | 171.84M | 171.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |